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During the last two decades, interest relating to mitochon-
dria in the field of aging has grown exponentially. Nowadays,
it is known that mitochondria are more than just the power-
houses of the cell. They participate in almost every aspect
of metabolism. The more we learn about mitochondria,
the more fascinating they become and the more they seem
to be implicated in aging. Originally, the gerontological
community became interested in mitochondria due to their
role in the generation of reactive oxygen species (ROS).
D. Harman proposed his renowned free radical theory of
aging in 1956 [1], reformulating it 16 years later as the
mitochondrial free radical theory of aging (MFRTA) [2]
in order to emphasise the fact that mitochondria were
simultaneously both the main generators and the main
targets of free radicals. Since then, many laboratories have
published an extensive volume of data both supporting and
refuting the MFRTA. Presently, new theories have been put
forward suggesting a role for mitochondria in aging which is
independent of the generation of ROS. For example, it has
been proposed that aging is caused by the accumulation of
mutations and large-scale deletions in mitochondrial DNA
(mtDNA), which may partly arise from the inherent error
rate of mtDNA polymerase gamma rather than oxidative
damage [3]. It has also been proposed that aging can be
caused by an alteration of the redox homeostasis, since
mitochondria regulate the relative levels of NADH/NAD+,
NADPH/NADP+, and GSH/GSSG [4].
The considerable attention that mitochondria have
attracted is well represented in this special issue. Diﬀerent
authors present new discoveries from their laboratories or
review the latest advances in their fields of expertise. The
role of mtDNA in aging and cancer is a popular and
highly debatable topic. This is illustrated by three articles
in the “Mitochondria and Aging” special issue. Specifically,
R. Gredilla in “DNA damage and base excision repair in
mitochondria and their role in aging” describes the substantial
progress that has been achieved in understanding the repair
mechanisms relevant to mtDNA. It is currently known that
mtDNA has a sophisticated repair system adapted to the
particular needs of an environment characterised by high
levels of ROS. C. Desler et al. in “The importance of mito-
chondrial DNA in aging and cancer” and A.M. Czarnecka and
E. Bartnik in “The role of the mitochondrial genome in ageing
and carcinogenesis” analyse the contribution of mitochondria
to both the origin and progression of cancer. Several inter-
esting correlations are revealed; however, further research
is needed before more definite conclusions can be reached.
This will require the implementation of new techniques to
measure every aspect of mitochondrial function in detail in
combination with high-throughput screening. L. Staunton
et al. in “Proteomic profiling of mitochondrial enzymes during
skeletal muscle aging” describe how proteomic profiling can
help to achieve this, whereas E. Barbieri et al. in “Morpho-
functional and biochemical approaches for studying mitochon-
drial changes during myoblasts diﬀerentiation” demonstrate a
practical application of the techniques in the study of cellular
fate. Although the role of mitochondria in cell diﬀerentiation
is not yet understood, available data indicate that they play
a major role and that certain changes in mitochondrial
function are essential to complete cellular diﬀerentiation.
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Dietary restriction (DR) is the most widely used inter-
vention to extend lifespan. Currently, numerous laboratories
worldwide are searching for genetic targets that will allow an
increased lifespan without reducing the number of calories.
It is well established that mitochondria are major contrib-
utors to the cellular adaptations needed to prolong lifespan
during DR. However, the mechanisms or pathways involved
have yet to be completely elucidated. Organisms with a
short lifespan, such as yeast, oﬀer an excellent opportunity
for screening. B. Li et al. in “Identification of potential
calorie restriction-mimicking yeast mutants with increased
mitochondrial respiratory chain and nitric oxide levels” use
this approach to identify new genes implicated in lifespan
extension by DR. For example, they show evidence that nitric
oxide produced by complex IV triggers changes that elicit
lifespan extension. Several mechanisms have been proposed
to underlie the increase in lifespan by DR, an increase in
the deacetylase activity of sirtuins and an augmentation of
mitochondrial biogenesis being two of them. G. R. Wagner
and R. M. Payne in “Mitochondrial acetylation and diseases
of aging” discuss the role of mitochondrial deacetylases in
aging. The importance of mitochondrial sirtuins has recently
been documented by articles describing their essential role in
the activation of protection against oxidative damage during
DR [12, 13]. Mitochondrial biogenesis is another leading
topic in aging research. One of the major regulators of this
process is peroxisome-proliferator-activated receptor gamma
coactivator 1-alpha (PGC-1α). T. Wenz in “Mitochondria
and PGC-1α in aging and age-associated diseases” discusses
the alteration of mitochondrial biogenesis in aging and how
PGC-1α can be used as a novel therapy. New treatments are
needed to protect against neurodegenerative diseases, one
of the most devastating consequences of aging. Calcium is
a key player in the intercommunication of diﬀerent cellular
organelles as reviewed by J. P. Decuypere et al. in “IP3
receptors, mitochondria, and Ca2+ signaling: implications for
aging.” Upon intercommunication damage, cellular home-
ostasis is lost, resulting in cellular death or transformation.
R. Kumar and H. Atamna in “Therapeutic approaches to delay
the onset of Alzheimer’s disease” propose two complementary
approaches to delay the onset of Alzheimer’s disease. Boost-
ing mitochondrial metabolism should decrease amyloid-
β peptide accumulation. Coincidentally, exercise increases
mitochondrial function and decreases the concentration of
markers of Alzheimer’s disease [16]. Deregulation of metal
transition homeostasis is increasingly recognized as a major
problem during aging [17].
If the past is described as good and the present as promi-
sing, then the future will likely be very bright. However, there
are many challenges that must be overcome to understand
completely the role of mitochondria in aging and enable the
development of new therapeutic approaches. The develop-
ment of new techniques to study mitochondrial function
in vivo is of the utmost priority. Most of our knowledge
about how mitochondria work is based on data from isolated
organelles. As in vitro systems are prone to artifacts, an in vivo
approach would provemuchmore reliable. Cell culture oﬀers
an alternative approach, but is restricted by the fact that
oxygen pressure is a major determinant of mitochondrial
function and levels used are often not representative of
physiological concentrations. For success, we must aim for
excellence. Therefore, we must strive for the situation which
enables the quantification of measurements in model organ-
isms and human patients in vivo. Diﬃcult? Maybe. Possible?
Yes. In summary, for all of us interested in understanding
these fascinating organelles, we are living in exciting times.
But if we work hard, the future will be even more promising.
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